Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

Atherosclerosis

Volumn 154, Issue 3, 2001, Pages 529-537

  Lahoz, Carlos ^a   Schaefer, Ernst J ^a   Cupples, L Adrienne ^b   Wilson, Peter W F ^c   Levy, Daniel ^c   Osgood, Doreen ^a   Parpos, Stefanos ^a   Pedro Botet, Juan ^a   Daly, Jennifer A ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Cardiovascular disease; Genetic variation; Lipoproteins; Population studies

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; DNA; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ALLELE; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CHILD; COHORT STUDIES; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEX DISTRIBUTION;

EID: 0035864632     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00570-0     Document Type: Article

References (68)

1. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
2. Familial lipoprotein disorders in patients with premature coronary artery disease
3. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
4. A receptor-mediated pathway for cholesterol homeostasis
5. Molecular basis of familiar hypercholestolemia
6. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
7. Apolipoprotein E polymorphism and atherosclerosis
8. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms
9. Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations
10. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health
11. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites
12. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: Results from the Framingham Offspring Study
13. Human apolipoprotein E: The complete amino acid sequence
14. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis
15. Apolipoprotein E alleles and risk of coronary disease - A meta-analysis
16. Epidemiological approaches to heart disease: The Framingham Study
17. An investigation of coronary heart disease in families: The Framingham Offspring Study
18. A simple salting out procedure for extracting DNA from human nucleated cells
19. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
20. The coronary primary prevention trial: Design and implementation
21. The coronary primary prevention trial: Design and implementation: The Lipid Research Clinics Program
22. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia
23. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease
24. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease
25. Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease
26. Hyperlipoproteinemia as a risk factor for ischemic heart disease
27. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease
28. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: The ECTIM study
29. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: The Framingham Offspring Study
30. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men
31. Apolipoprotein E phenotypes in patients with myocardial infarction
32. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction
33. Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population
34. Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction
35. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: A case-control study
36. Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease
37. Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease
38. The role of the apolipoprotein E polymorphism in the prediction of coronary artery disease age of onset
39. Apolipoprotein E genotypes in offspring with a positive and negative family history of premature myocardial infarction
40. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: The EARS Study
41. Apolipoprotein E polymorphism and coronary artery disease
42. Apolipoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients
43. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease
44. Apolipoprotein ε4 homozygosity in young men with coronary heart disease
45. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women
46. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography
47. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis
48. The relationship between risk factor levels and presence of coronary artery calcification is dependent on apolipoprotein E genotype
49. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults
50. Apolipoprotein E polymorphisms affect atherosclerosis in young males
51. Apolipoprotein E and atherosclerosis in Alaska Natives
52. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men - An autopsy study
53. Lipid profiles reflecting high and low risk for coronary heart disease: Contribution of apolipoprotein E polymorphism and lifestyle
54. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations
55. Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: The EARS II study. European Atherosclerosis Research Study
56. Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype, A report from the Multiple Risk Factor Intervention Trial
57. Mechanisms of postprandial hyperlipidemia - Remnants and coronary artery disease
58. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
59. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein
60. Apolipoprotein E2 transgenic rabbits
61. Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway
62. Genes, variation of cholesterol and fat intake and serum lipids
63. The genetics of serum lipid responsiveness to dietary interventions
64. Apolipoprotein E phenotype and diet-induced alteration in blood pressure
65. The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle
66. Genetic studies of human apolipoproteins. XVI. APOE polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico
67. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia
68. High frequency of the apo epsilon 4 allele in Khoi San from South Africa